Nirland Ltd - 30 Sep 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
10%+ Owner
Signature
Nirland Limited, By: /s/ David Rowland, Director
Issuer symbol
CDT
Transactions as of
30 Sep 2024
Net transactions value
-$297,644
Form type
4
Filing time
02 Oct 2024, 17:02:22 UTC
Previous filing
13 Aug 2024
Next filing
07 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDT Common Stock, par value $0.0001 per share Sale $122,019 -1,016,823 -8.1% $0.1200 11,483,177 30 Sep 2024 Direct F1
transaction CDT Common Stock, par value $0.0001 per share Sale $141,375 -1,250,000 -11% $0.1131 10,233,177 01 Oct 2024 Direct F1
transaction CDT Common Stock, par value $0.0001 per share Sale $34,251 -333,177 -3.3% $0.1028 9,900,000 02 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.